|
Volumn 5, Issue 1, 2009, Pages 6-7
|
Cholesterol Paves the Way for Topically Applied Viricides
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
CHOLESTEROL;
INTERFERON;
SMALL INTERFERING RNA;
ANTIVIRAL ACTIVITY;
CLINICAL TRIAL;
DRUG CONJUGATION;
DRUG EFFICACY;
DRUG STABILITY;
ENCAPSULATION;
GENE DELIVERY SYSTEM;
GENE EXPRESSION;
GENE INDUCTION;
HERPES VIRUS;
HERPES VIRUS INFECTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOCOMPETENT CELL;
INFECTION PREVENTION;
NONHUMAN;
PATHOGENICITY;
PRIORITY JOURNAL;
RNA INTERFERENCE;
SEXUALLY TRANSMITTED DISEASE;
SHORT SURVEY;
VIRUS INFECTION;
WART VIRUS;
ANIMALS;
ANTI-INFECTIVE AGENTS, LOCAL;
ANTIVIRAL AGENTS;
CHOLESTEROL;
MICE;
RNA, SMALL INTERFERING;
HERPESVIRIDAE;
MUS;
|
EID: 58249084170
PISSN: 19313128
EISSN: None
Source Type: Journal
DOI: 10.1016/j.chom.2008.12.005 Document Type: Short Survey |
Times cited : (6)
|
References (11)
|